| Peer-Reviewed

Psychiatric Comorbidity and Quality of Life in Persons with Diabetes Melitus and People Living With Hiv (Plwhiv) in Port Harcourt, Nigeria

Received: 24 December 2015    Accepted: 13 January 2016    Published: 1 February 2016
Views:       Downloads:
Abstract

Diabetes mellitus and HIV are two chronic medical diseases associated with psychiatric comorbidity, which further affect the quality of life of the sufferers. The aim of this study, therefore, was to determine and compare the relationship between psychiatric comorbidity and quality of life in persons with diabetes mellitus and PLWHIV. Following ethical approval from the appropriate committee of the hospital and informed consent from the participants, 230 subjects living with HIV and 120 subjects with diabetesmelitus were recruited based on the study’s inclusion and exclusion criteria. This was after a pilot study. Subjects were further administered with the study’s instruments including the socio-demographic questionnaire, GHQ-12, the brief version of the WHO Quality of Life instrument (WHOQOL-Bref) and WHO Composite International Diagnostic Interview (WHO CIDI). The socio-demographic questionnaire, GHQ-12 and WHOQOL-Bref were self-administered while the WHO CIDI was based on interview by the researcher. The data were analyzed using the SPSS version 20 statistical package. Confidence interval was set at 95% while P- value of less than 0.05 was considered statistically significant. The study found a prevalence of psychiatric co-morbidity of 17.3% among PLWHIV. For PLWHIV, domain scores quality of life were as follows; 60.71±15.57, 62.34±26.32, 61.57±25.04, 55.15±14.00 and 65.81±21.84 for physical, psychological, social relationship, environment domains and general health facet respectively. For persons with diabetes mellitus, domain scores quality of life were as follows; 51.97+ 14.671, 56.20+ 22.186, 57.51 + 26.13, 52.01+ 16.91and 48.34 + 22.44for physical, psychological, social relationship, environment domains and general health facet respectively. Furthermore, presence of psychiatric comorbidity significantly inversely correlated with quality of life among persons with both medical diseases. The findings in this study indicate diabetis mellitus and HIV infection are both chronic debilitating illnesses, associated with psychiatric co-morbidity, which significantly inversely correlated with quality of life of the sufferers. The results indicate that the management of both medical conditions should include attention to their mental health status and subjective quality of life of these patients in order to enhance the quality of care.

Published in American Journal of Psychiatry and Neuroscience (Volume 3, Issue 6)
DOI 10.11648/j.ajpn.20150306.17
Page(s) 154-164
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Correlation, Comorbidity, QOL, Diabetes Melitus, PLWHIV, UPTH

References
[1] Centres for Disease Control and Prevention HIV/AIDS Surveillance Report, 2004; 12 (No. 1): 1-42.
[2] King H, Aubert RE, Herman WH. Global burden of diabetes, 1995/2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414/31.
[3] Vilbergsson S, Sigurdsson G, Sigvaldason H, Hreidarsson AB, Sigfusson N. Prevalence and incidence of NIDDM in Iceland: Evidence for stable incidence among males and females 1967/1991/the Reykjavik Study. Diabet Med 1997; 14: 491/8.
[4] Kolson DL, Lavi E, Gonzalex - Scarano, F. The Effects of HIV on the Central Nervous System. Adv Virus Res. 1998; 50: 1-47.
[5] ] Johansen J, Claudi T, Holtedahl K. Insulin treatment for poorly regulated diabetic patients in general practice. Better regulation and symptom relief? Scand J Prim Health Care 1999; 17: 244/9.
[6] Barroso J, Hammill B, leseman J, Salahuddin N, Hamon J, Pence B. Physiological and psychosocial factors that predict HIV-related fatigue. AIDS Behav. 20l0; 4: l415-27.
[7] Stevens P, Tighe Doerr B. Trauma of discovery: women’s narrative of being Informed they are HIV-Infected. AIDS Care 1997; 9: 523-38.
[8] Bharat S, Aggleton P. Facing the challenge: household responses to AIDS in Mumbai, India. AIDS Care. 1999; 11; 31-44.
[9] Windle M., 1997. The trading of sex for money or drugs, sexually Transmitted Diseses (STDs) and HIV related risk behaviors among polysubstance use and alcoholic inpatients. Drug. Alcohol Depend. 1997; 49: 33-38.
[10] Susser E., Valencia E, Miller M., Tsai WY, Meyer-Bahlburg H. & Conover S. Sexual behavior of homeless mentally ill men at risk for HIV. American Journal of Psychiatry 1995; 1552: 583-587.
[11] Watters JK, EstilioMJ, Clark GL &Lorvick, J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994; 271: 115-120.
[12] Herek GM, Capitanio J P. AIDS stigma and sexual prejudice Am BehavSci 1999; 42: 1130-45.
[13] Fife BL, Wright ER. The dimensionality of stigma: A comparison of its impact on the self of persons with HIV/ AIDS and cancer. J Health SocBehav 2000; 41: 50-67.
[14] Herek GM, GluntEK. An epidemic of stigma: public reactions to AIDS: Am Psychol. 1988; 43: 886-91.
[15] Herek GM. AIDS and Stigma. AmBehav Science 1999; 42: 1106-16.
[16] Bird ST, Bogart LM, Delahanty DL. Health-related correlates of perceived discrimination in HIV care. AIDS Patient Care STDs 2004; 18: 19-26.
[17] Holtgrave DR, Pinkerton SD. Update of Cost of Illness and Quality of life Estimates for use in Economic Evaluations of HIV Presentation Programs J. Acquir Immune DeficSyndr Gum Retroviral. 1997; 16: 54-62.
[18] Letendre S., Margule-Beck J, Capparell E, et al. CHARTER Group. Validation of the CNS Penetration- Effectiveness rank for quantifying antiretroviral penetration Into the central nervous system. Arch Neurol. 2008; 66: 65-70.
[19] Clark U, Cohen R. Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infection individuals. CurrOpin Investing Drugs. 2010; 11: 884-900.
[20] Murray CJ, Lopez AD. Mortality by cause for eight regions of the world. Global burden of disease. Lancett, 1997; 349: 1269-1276.
[21] Cook J, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multiside cohort of HIV-positive women. Am J Public Health 2004; 94: 1133-40.
[22] Aalto AM, Uutela A, Kangas T. Health behaviour, social integration, perceived health and dysfunction. A comparison between patients with type I and II diabetes and controls. Scand J Soc Med 1996; 24: 272/81. Catalan J, Burgess A, Klimes I. Psychological Medicine of HIV infection. Oxford: Oxford University Press,
[23] Grassi I, Right A, Sighinolfi L, Makoui S, Ghinelli F. Coping styles end psychosocial-related variables in HlV- Infected patients. Psychcomatics 1998; 39: 350-9.
[24] Wolf T, Balson P, Morse E. Relationship of coping style to affective state and perceived social support in asymptomatic and symptomatic HIV-Infected persons: Implications for clinical management J Clin psychiatry. 1991; 52: 171-3.
[25] Nichotaon W, Long B. Self-esteem, social support, internalized homophiobia, and coping strategies of HIV+ gay men. J Consult ClinPsyohcl. 1990; 50-873-6. 53.
[26] Grassi I. Right A, Sighinolfi L, Makoui S, Ghinelli F. Coping styles and psychosocial-related variables in HlV- Infected patients. Psychcomatics. 1998; 39: 350-9.
[27] Heaton B, Velin B, McCutchan J, et al. Neuropsychological Impairment in HIV Infections: implications for employment HNRC Group- HIV, Neurobehavioral Research Center. Psychosom Med. 1984; 56: 8-17.
[28] Marcotte T, Lazzaretto D, Scott J, Roberta C, Woods S, Letendre S. Visual attention deficits are asaociated with driving accidents In cognitively-impaired HIV-Infected individuals. J ClinExpNeuropsychol. 2006; 28: 13-28.
[29] Wredling R, Adamson U, Berne C, Dahle´n M. O ¨ stman J, Larsson Y, et al. Quality of life among a representative sample of people with diabetes mellitus in Sweden. DiabNutrMetab 1993; 6: 393/5.
[30] American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Press; 1994.
[31] Pita R, Fotakopoulou O, Kiosseoglou G, Zafiri M, Roikou K, Simos G, et al. Depression, quality of life and diabetes mellitus. HIPPOKRATIA 2002; 6: 44-47.
[32] Ribu L, Wahl A. How patients with diabetes who have foot and leg ulcers perceive the nursing care they receive. J Wound Care 2004; 13: 65/8.
[33] Barroso J, Hammill B, leseman J, Salahuddin N, Hamon J, Pence B. Physiological and psychosocial factors that predict HIV-related fatigue. AIDS Behav. 20l0; 4: l415-27.
[34] Johnson J, Williams J, Rabkin J, et al. Axis 1 psychiatric symptomatology associated with HIV Infection and personality disorder. Am J Psychiatry. 1995; 152: 551-4.
[35] Gala C, Pergami A. Catalan J, et al. The psychosocial impact of HIV infection on gay men, drug users and heterosexuals. Controlled Investigation. Br J Psychiatry. 1993; 163: 661-9.
[36] Dilley J, OchitiIl M, Peri M, volderbing R. Findings in psychiatric consultations with patients with AIDS. Am J Psychiatry. 1985; 142: 82-6.
[37] Celsia J, Roberts J. Meta-analysis of the relationship between HIV Infection and risk for depressive disorders. Am J Psychiatry. 2001; 158: 725-30.
[38] Lyketsos C, Hoover D, Guccione M, et al. Changes In depressive symptoms as AIDS develops: The Multicenter AIDS Cohort Study. Am J Psychiatry. 1996; 153: 1430-7.
[39] Myers H, Durvasula B. Psychiatric disorders In African, American men and women living with HIV/AIDS. Cult DivEthn Min Psychol. 1999; 5: 249-62.
[40] Dew M, Becker J, Sanchez J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med. 1997; 27: 395-409.
[41] Roberts RE, Kaplan GA, Camacha TO. Psychological distress and mortality: evidence from the Alameda County Study. SocSc) Mad. 1990; 31: 527-530.
[42] Lipsitz J, Williams J, Rabkin, et al. Psychopathology in male and female drug users with and without HIV Infection. Am J Psychiatry. 1994; 151: 1662-8.
[43] Rosenberger P, Bonsterin R, Nasralliah H, et al. Psychopathology in HIV: lifetime and current assessment. Compr Psychiatry. 1993; 34: 150-8.
[44] McDowell J, Chittick G, Stevens C, Edwards K, Stein D. Pharmacokinetic Interaction of abacavir (159U89) and ethanol In HIV infected adults. Antimicrob Agents Chemoter. 2000; 44: 1686-90.
[45] Antoniou T, Tseng A. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother. 2002; 36: 598-613.
[46] Lyketsos C, Hoover D. Guccione M, et al. Changes In depressive symptoms as AIDS develops: The Multicenter AIDS Cohort Study. Am J Psychiatry. 1996; 153: 1430-7.
[47] Johnson RT. HIV in Viral Infections of the Nervous System (2nd Edition). Johnson A (Ed). lippincott-Raven, PA. USA, 1998; 287-313
[48] Rottenberg D, Moeller J, Strother S, et al. The metabolic pathway of the AIDS dementia compIex Ann Neurol. 1987; 22: 700-6.
[49] Grant I, Atkinson J, Hesselink J, et al. Evidence for early central nervous system involvement in AIDS and other HIV infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987; 107: 828-36.
[50] Heaton A, Grant I, Butters N, et al. The HNRC neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. J IntNeuropsycholSoc 1995; 1: 231-51.
[51] Center for Disease Control and Prevention. Prevention and Treatment of Tuberculosis Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations. MMWRMorb Mortal Wkly Rep. 1998; 47 (RR-20): 1-51.
[52] Gwatkin D, Guillot M, Heuveline P. The burden of disease among the global poor. Lancet, 2000; 354: 586-589.
[53] Frasure-Smith N, Lesperance F. Reflections on depression as a cardiacriskfactor. Psychosom Med 2005; 67: S19-25.
[54] Ola BA, Adewuya AO, AjayiOE, Akintomide AO, OginniOO, OlogunYA. Relationship between depression and quality of life in Nigerian outpatients with heart failure. J Psychosom Res 2006; 61: 797-800.
[55] Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. IntClinPsychopharmacol 2000; 15: 319–28.
[56] Anderson RB, Testa MA. Symptom Distress Checklists as a Component of Quality-of-Life Measurement Comparing Prompted Reports by Patient and Physician with Concurrent Adverse Event Reports Via the Physician. Drug inf. J. 1994; 28: 89-14.
[57] Lenderking WR, Gelber RD, Cotton DL, et al. Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus Infection. N Engl. J. Med. 1994; 330: 738-43.
[58] Nebhinanl N, Mattoo S, Wanchu A. Psychiatric morbidity in HIV-positive subjects: a study from India. The Psychosom Res. 2011; 70: 449-54.
[59] Olusina AK, OhaeriJU, Subjective quality of life of recently discharged Nigerian Psychiatric patients. Soc Psychiatry Epidemiol 2003; 38 (12): 707-4.
[60] Concepts of Health-Related Quality of Life. In: Patrick D. L, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press, 1993; 76-112.
[61] Testa MA, LenderkingWR. Interpreting pharmacoeconomic and quality-of –life clinical trial data for use in therapeutics. Pharmacoeonomics. 1992; 2: 107-17.
[62] Olisah VO, Biayewu O, Sheikh TL. Depression Underdiagnosis and the effects on quality of life in outpatients with HIV at a Nigerian University Teachng Hospital. African Journal of AIDS Research, Volume 10, Number 3, 2011; pp 247-254 (8).
[63] Wells K, Golding J, Burman M. Psychiatric disordesrIn a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 1988; 145: 976-81
[64] Evans D, Charney D. Mood disorders and medical illness a major public health problem. Blot Psychiatry. 2003; 64: 177-80.
[65] Sweet MD, & Denison JA. Reducing HIV incidence in developing countries with structural and environmental interventions AIDS. 1995; 9: S251-S2577.
[66] Hiyasu Z, Kabir M, Abubarkar IS, Babashani M, ZubairZA. Compliance to antiretroviral therapy among AIDSs patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Nigerian J. Med., 2005; 14: 290-295.
[67] Catalan J. HIV-1 associated psychotic disorders. ClinNeuropharmacoh. 1999; 15 (Suppt 1) 368-9.
[68] Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997; 20: 585–90.
[69] Mawar N, Kohli R, Joglekar N, Bagul R. Children and Young People in Context of HIV/AIDS: Listen, Learn and Live! World AIDS Day Campaign with Children and Young People. ICMR Bull 1999; 29: 125-35.
[70] Schoepf BG. Culture, sex research and AIDS prevention in Africa. In: Brummelhuis H, Herdt G, editors. Culture and sexual risk. Anthropological perspectives on AIDS. Amsterdam: Gordon and Breach Publishers; 1995.
[71] Kalichman SC, Ramachandran B, &Catz, S. Adherence to combination antiretroviral therapies in HIV seropositive men and women of low health literacy: Journal of General Internal Medicine, 1999; 14267-273.
[72] Crosby G, Stall R, Paul J, Barrett D. Substances use and HIV risk profile of gay/bisexual males who drop substance abuse treatment AIDS Educ Prev. 2000; 12: 38-48.
[73] Morrison MF, Prtitto JM, Ten Hanc T, Grttes DR, Chiappini MS, Weber AL, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiarty.
[74] Chandra PS, Ravi V, Desai A. Anxiety and depression among HIV-infected heterosexuals- A report from India. J Psychosom Res 1998; 45: 401-9.
[75] Nor K, Tlou S, Norr J. The Threat of AIDS for Women in Developing Countries. In: Cohen F, Durham JD, Editors Women Children and HIV, New York; Springer Publishing Co; 1993; p. 263.
[76] Demi A, Bakeman R, Richard S, Linda M, Brenda S. Suicidal thoughts of women with HIV infection: effect of stressors and moderating effects of family cohesion. J FamPsychol 1998; 12: 344-53.
[77] Atkinson J, Grant I, Natural history of neuropsychiatric manifestations of HIV disease. Psych Clin North America. 1994; 17: 17-33.
[78] Perry S, Jacobsberg L, Fishman B. Suicidal ideation and HIV testing. JAMA. 1990; 263: 679-682.
[79] HaIler D. Miles D. Suicidal ideation among psychiatric patients with HIV psychiatric morbidity and quality of life. AIDS Behav. 2003; 7: 101. 8.
[80] Gala C, Pergami A, Catalan J, et al. Risk of deliberate self-harm and factors associated with suicidal behaviour among asymptomatic Individuals with HIV Infection, ActaPsychiatrScand, 1992; 86: 70-5,
[81] Jacob KS, John JK, VerghesEA, John TJ. The fear of AIDS: Psychiatric symptom or syndrome? AIDS Care 1989; 1: 13-6.
[82] Herek GM, Capittanio JP. Public reactions to AIDS in the United States: A second decade of stigma. Am J Public Health 1993; 83: 574-7.
[83] Maman S. Mbwambo 1K, Hogan NM, Kilozo JP, Campbell JC, Weiss E, et al. HIV- positive women report more lifetime partner violence: Findings from a voluntary counseling and testing clinic in Dar-es-Salaam, Tanzania. Am J Public Health 2002; 92: 133 1-7.
[84] Chander G, Josephs J, Fleismann J, et al. Alcohol use among HIV- Infected Persons in care: results of a multisite survey. HIV Med. 2009; 9: 196-202.
[85] Green J, Saveanu R, Bornstein B. The effect of previous alcohol abuse on cognitive function in HIV Infection. Am J Psychiatry. 2004; 161: 249-54.
[86] Bing E, Burman M, Longshore D, et al. Psychiatric disorders and drug use among HIV-infected adults in the United Stales, Arch Gen psychiatry 2001; 58: 721- 8.
[87] Reine G, Lancon C, Di Tucci S, Sapin C, Auquier P. Depression and subjective quality of life in chronic phase schizophrenic patients. ActaPsychiatrScand 2003; 108: 297-303.
[88] Perkins DO, Stein RA, Golden RN, Murphy C, Naftolowiz D. Evans DL. Mood disorders in HIV Infection. Prevalence and risk factors in a non epicenter of the AIDS epidemic. Am J. Psychiatry 1994; 15: 233-6.
[89] The World Bank (2008) 'Nigeria receives US million additional funding for HIV/AIDS project program'.
[90] National Agency for the Control of AIDS (NACA) (2009, December) 'National HIV/AIDS strategic framework (NSF) 2010-15'.
[91] Cooper RS, Rotimi C. Establishing the epidemiologic basis for prevention of cardiovascular diseases in Africa. Ethn Dis. 1993; 3: 513-522.
[92] Larsson D, Lager I, Nilsson PM. Socio-economic character Istics and quality of life in diabetes mellitus / relation to metabolic control. Scand J Public Health 1999; 27: 101/5.
[93] Lyketsos CG, Hanson AL, Fishman M, Rosenblatt A, McHugh PR, Treisman GJ. Manic syndrome early and late in the course of HIV. Am J Psychiatry 1993; 150: 326-7.
[94] Kelly J, Murphy D, Bahr G, et al. Factors associated with severity of depression and high risk sexual behavior among persons diagnosed with HIV infection. Health Psychol. 1993; 12. 215-19.
[95] Gureje O. Uwakwe R. Oladeji, B, Makanjuola, V. O. and Esan O. Depression in Adult Nigerians. Result from the Nigerian Survey of mental health and wellbeing. Journal of Affective Disorders. Doi 10.1016/j.jas.2009; 04.030.
[96] Koete MW, Van den Brink, W. and Ormei J. Chronic Psychiatric. Complaints and the General Health Questionnaire. Br. J. Psychiat. 1989; 155, 186-190.
[97] Adamson TA, and Sijuwola, OA. Ilewo-Orile. Nigerian Epidemiological Study: Psychiatric morbidity in a rural community using the 12-item GHO, Nigerian Journal of Psychiatry. 2001; Vol. 1, No5: 315-321.
[98] Gureje O, and Obikoya B. The GHQ – 12, as a screening tool in a primary care setting. Social Psychiatry and Psychiatric Epidemiology. 1990; 25: 276-280.
[99] Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. Jama 1989; 262: 907-913.
[100] Gaede P, Beck M, Vedel P, Pedersen O. Limited impact of lifestyle education in patients with Type 2 diabetes mellitus and microalbuminuria: Results from a randomized intervention study. Diabet Med 2001; 18: 104/8.
[101] Nkporbu A. K, Ugbomah L, Stanley P. C. Pattern and Prevalence of Psychiatric Consultations inOther Non- Psychiatric In-patient Facilities in the University of Port Harcourt Teaching Hospital: A 5-YEAR REVIEW. The Nigerian Health Journal. 2014; 14; 1, 13-20.
[102] Bowling A. What thing are important in peoples life? A survey of the public’sjudgements to informscales of Health related QOL. Soc. Sci. Med. 1995; 41: 1447-62.
[103] Bowling A. Quality of life in Social Science and Medicine. Soc. Sci. Med. 1995; 41: 1337-1338.
[104] World Health Organisation. WHO constitution: the first chapter. Electronic citation WorldWideWeb200: http//www.idb.org/iphw/whoconst.htm Cited on 13/5/2009.
[105] Okunoye O. C., Asekomeh G. E., Iyagba M. A., Owuchekwa A. C. Qualiti of life of people living with HIV/AIDS in Port Harcourt. The Nig Health J. 2014; 14: 8-12.
Cite This Article
  • APA Style

    Nkporbu Aborlo Kennedy, Korubo Ibitrokoemi Faye, Stanley Princewill Chukwuemeka. (2016). Psychiatric Comorbidity and Quality of Life in Persons with Diabetes Melitus and People Living With Hiv (Plwhiv) in Port Harcourt, Nigeria. American Journal of Psychiatry and Neuroscience, 3(6), 154-164. https://doi.org/10.11648/j.ajpn.20150306.17

    Copy | Download

    ACS Style

    Nkporbu Aborlo Kennedy; Korubo Ibitrokoemi Faye; Stanley Princewill Chukwuemeka. Psychiatric Comorbidity and Quality of Life in Persons with Diabetes Melitus and People Living With Hiv (Plwhiv) in Port Harcourt, Nigeria. Am. J. Psychiatry Neurosci. 2016, 3(6), 154-164. doi: 10.11648/j.ajpn.20150306.17

    Copy | Download

    AMA Style

    Nkporbu Aborlo Kennedy, Korubo Ibitrokoemi Faye, Stanley Princewill Chukwuemeka. Psychiatric Comorbidity and Quality of Life in Persons with Diabetes Melitus and People Living With Hiv (Plwhiv) in Port Harcourt, Nigeria. Am J Psychiatry Neurosci. 2016;3(6):154-164. doi: 10.11648/j.ajpn.20150306.17

    Copy | Download

  • @article{10.11648/j.ajpn.20150306.17,
      author = {Nkporbu Aborlo Kennedy and Korubo Ibitrokoemi Faye and Stanley Princewill Chukwuemeka},
      title = {Psychiatric Comorbidity and Quality of Life in Persons with Diabetes Melitus and People Living With Hiv (Plwhiv) in Port Harcourt, Nigeria},
      journal = {American Journal of Psychiatry and Neuroscience},
      volume = {3},
      number = {6},
      pages = {154-164},
      doi = {10.11648/j.ajpn.20150306.17},
      url = {https://doi.org/10.11648/j.ajpn.20150306.17},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpn.20150306.17},
      abstract = {Diabetes mellitus and HIV are two chronic medical diseases associated with psychiatric comorbidity, which further affect the quality of life of the sufferers. The aim of this study, therefore, was to determine and compare the relationship between psychiatric comorbidity and quality of life in persons with diabetes mellitus and PLWHIV. Following ethical approval from the appropriate committee of the hospital and informed consent from the participants, 230 subjects living with HIV and 120 subjects with diabetesmelitus were recruited based on the study’s inclusion and exclusion criteria. This was after a pilot study. Subjects were further administered with the study’s instruments including the socio-demographic questionnaire, GHQ-12, the brief version of the WHO Quality of Life instrument (WHOQOL-Bref) and WHO Composite International Diagnostic Interview (WHO CIDI). The socio-demographic questionnaire, GHQ-12 and WHOQOL-Bref were self-administered while the WHO CIDI was based on interview by the researcher. The data were analyzed using the SPSS version 20 statistical package. Confidence interval was set at 95% while P- value of less than 0.05 was considered statistically significant. The study found a prevalence of psychiatric co-morbidity of 17.3% among PLWHIV. For PLWHIV, domain scores quality of life were as follows; 60.71±15.57, 62.34±26.32, 61.57±25.04, 55.15±14.00 and 65.81±21.84 for physical, psychological, social relationship, environment domains and general health facet respectively. For persons with diabetes mellitus, domain scores quality of life were as follows; 51.97+ 14.671, 56.20+ 22.186, 57.51 + 26.13, 52.01+ 16.91and 48.34 + 22.44for physical, psychological, social relationship, environment domains and general health facet respectively. Furthermore, presence of psychiatric comorbidity significantly inversely correlated with quality of life among persons with both medical diseases. The findings in this study indicate diabetis mellitus and HIV infection are both chronic debilitating illnesses, associated with psychiatric co-morbidity, which significantly inversely correlated with quality of life of the sufferers. The results indicate that the management of both medical conditions should include attention to their mental health status and subjective quality of life of these patients in order to enhance the quality of care.},
     year = {2016}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Psychiatric Comorbidity and Quality of Life in Persons with Diabetes Melitus and People Living With Hiv (Plwhiv) in Port Harcourt, Nigeria
    AU  - Nkporbu Aborlo Kennedy
    AU  - Korubo Ibitrokoemi Faye
    AU  - Stanley Princewill Chukwuemeka
    Y1  - 2016/02/01
    PY  - 2016
    N1  - https://doi.org/10.11648/j.ajpn.20150306.17
    DO  - 10.11648/j.ajpn.20150306.17
    T2  - American Journal of Psychiatry and Neuroscience
    JF  - American Journal of Psychiatry and Neuroscience
    JO  - American Journal of Psychiatry and Neuroscience
    SP  - 154
    EP  - 164
    PB  - Science Publishing Group
    SN  - 2330-426X
    UR  - https://doi.org/10.11648/j.ajpn.20150306.17
    AB  - Diabetes mellitus and HIV are two chronic medical diseases associated with psychiatric comorbidity, which further affect the quality of life of the sufferers. The aim of this study, therefore, was to determine and compare the relationship between psychiatric comorbidity and quality of life in persons with diabetes mellitus and PLWHIV. Following ethical approval from the appropriate committee of the hospital and informed consent from the participants, 230 subjects living with HIV and 120 subjects with diabetesmelitus were recruited based on the study’s inclusion and exclusion criteria. This was after a pilot study. Subjects were further administered with the study’s instruments including the socio-demographic questionnaire, GHQ-12, the brief version of the WHO Quality of Life instrument (WHOQOL-Bref) and WHO Composite International Diagnostic Interview (WHO CIDI). The socio-demographic questionnaire, GHQ-12 and WHOQOL-Bref were self-administered while the WHO CIDI was based on interview by the researcher. The data were analyzed using the SPSS version 20 statistical package. Confidence interval was set at 95% while P- value of less than 0.05 was considered statistically significant. The study found a prevalence of psychiatric co-morbidity of 17.3% among PLWHIV. For PLWHIV, domain scores quality of life were as follows; 60.71±15.57, 62.34±26.32, 61.57±25.04, 55.15±14.00 and 65.81±21.84 for physical, psychological, social relationship, environment domains and general health facet respectively. For persons with diabetes mellitus, domain scores quality of life were as follows; 51.97+ 14.671, 56.20+ 22.186, 57.51 + 26.13, 52.01+ 16.91and 48.34 + 22.44for physical, psychological, social relationship, environment domains and general health facet respectively. Furthermore, presence of psychiatric comorbidity significantly inversely correlated with quality of life among persons with both medical diseases. The findings in this study indicate diabetis mellitus and HIV infection are both chronic debilitating illnesses, associated with psychiatric co-morbidity, which significantly inversely correlated with quality of life of the sufferers. The results indicate that the management of both medical conditions should include attention to their mental health status and subjective quality of life of these patients in order to enhance the quality of care.
    VL  - 3
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria

  • Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria

  • Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria

  • Sections